1. Home
  2. Present
  3. Speakers
SPEAKERS

 


  • What is New in Cytotoxic Cutaneous Lymphomas
    Joan Guitart, MD

    Northwestern Univ, Feinberg School of Medicine Chicago, IL

  • What is New in EBV+ T/NK Cell LPDs
    Leticia Quintanilla, MD

    Institute of Pathology, Univ. of Tubingen (Germany)

  • What is New in T-Prolymphocytic Leukemia
    Sa Wang, MD

    MD Anderson Cancer Center, Houston, TX



  • Emerging Molecular Subgroups in PTCL-NOS
    Javeed Iqbal, PhD

    Univ. of Nebraska, Omaha

  • Introduction to TFH lymphomas and PTCL-NOS
    Francisco Vega, MD PhD

    MD Anderson Cancer Center. Houston, TX

  • Beyond Cell-Surface Targets, Biomarker Informed Therapies in T-cell Lymphoma
    Steven Horwitz, MD

    Memorial Sloan Kettering, New York, NY

  • What is New in T/NK Lymphoblastic Leukemia
    Carlos Bueso-Ramos, MD

    MD Anderson Cancer Center, Houston, TX

  • Keynote: Mechanisms of Transformation in PTCL: Lessons From a Decade of Research
    Teresa Palomero, PhD

    Institute for Cancer Genetics-Columbia University

  • What is New in Anaplastic Large Cell Lymphomas
    Andrew Feldman MD

    Mayo Clinic

  • Introduction to the WS Platform
    Ab Rauf Shah, Ph.D.

    Univ. of Nebraska, Omaha